Drug repurposing for SARS-CoV-2 main protease: Molecular docking and molecular dynamics investigations

The current novel corona virus illness (COVID-19) is a developing viral disease that was discovered in 2019. There is currently no viable therapeutic strategy for this illness management. Because traditional medication development and discovery has lagged behind the threat of emerging and re-emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Omer, Samia E., Ibrahim, Tawasol M., Krar, Omer A., Ali, Amna M., Makki, Alaa A., Ibraheem, Walaa, Alzain, Abdulrahim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801302/
https://www.ncbi.nlm.nih.gov/pubmed/35128086
http://dx.doi.org/10.1016/j.bbrep.2022.101225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801302/
https://www.ncbi.nlm.nih.gov/pubmed/35128086
http://dx.doi.org/10.1016/j.bbrep.2022.101225

Ejemplares similares